| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c23895 _d23895 |
||
| 001 | BD-DhNSU-23895 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403070811.0 | ||
| 008 | 190403s2008 nyua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a9781420043877 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRS420 _b.A42 2008 |
| 245 | 0 | 0 |
_aAdvanced drug formulation design to optimize therapeutic outcomes / _cedited by Robert O. Williams, David R. Taft and Jason T. McConville _nVol. 172 |
| 260 |
_aNew York : _bInforma Healthcare, _cc2008. |
||
| 300 |
_aVolume 172 ; _bill. ; _c24 cm. |
||
| 650 | 0 | _aDrugs | |
| 650 | 4 | _aDesign | |
| 700 | 1 | _aWilliams, Robert O. | |
| 700 | 1 | _aTaft, David R. | |
| 700 | 1 | _aMcConville, Jason T. | |
| 942 |
_2lcc _cBK |
||